Toronto Globe and Mail: UB neurosurgeon quoted on controversial MS treatment

An editorial in the Toronto Globe and Mail suggests Canada has an obligation to be aggressive in determining whether a controversial new treatment for multiple sclerosis works, and reports UB will soon enroll 20 patients in a preliminary treatment study. The editorial quotes L. Nelson Hopkins, professor and chair of neurosurgery.